HCV感染-话题@MedSci

#HCV感染#

47篇内容 | 948人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1618990, encodeId=7f0316189902b, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=CGH：37项临床试验的数据分析表明，使用DAA治疗HCV感染与VZV再激活风险增加之间无关联, objectType=article, longId=217087, objectId=67e521e08795, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e521e08795, replyNumber=0, likeNumber=27, createdTime=2021-09-16, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e521e08795, moduleTitle=CGH：37项临床试验的数据分析表明，使用DAA治疗HCV感染与VZV再激活风险增加之间无关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e521e08795)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618989, encodeId=6ec91618989be, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=NEJM：预防慢性HCV感染的疫苗是否有效？, objectType=article, longId=207063, objectId=69b320e063a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69b320e063a8, replyNumber=0, likeNumber=38, createdTime=2021-02-13, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69b320e063a8, moduleTitle=NEJM：预防慢性HCV感染的疫苗是否有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69b320e063a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618988, encodeId=dfc0161898807, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle= Lancet Gastroen Hepatol：索非布韦联合雷迪帕韦治疗患有慢性肾病的HCV感染患者, objectType=article, longId=195640, objectId=ec43195640c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec43195640c1, replyNumber=0, likeNumber=35, createdTime=2020-06-12, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec43195640c1, moduleTitle= Lancet Gastroen Hepatol：索非布韦联合雷迪帕韦治疗患有慢性肾病的HCV感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec43195640c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618987, encodeId=0c1f161898e83, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=《2018年意大利肝病学会专家共识：免疫功能低下患者HCV感染》摘译, objectType=article, longId=165181, objectId=c57c16518139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57c16518139, replyNumber=0, likeNumber=22, createdTime=2019-04-30, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57c16518139, moduleTitle=《2018年意大利肝病学会专家共识：免疫功能低下患者HCV感染》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c57c16518139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618986, encodeId=a838161898605, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=NEJM：HCV感染供体的心肺移植, objectType=article, longId=165027, objectId=304816502e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=304816502e50, replyNumber=0, likeNumber=25, createdTime=2019-04-27, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=304816502e50, moduleTitle=NEJM：HCV感染供体的心肺移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=304816502e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618985, encodeId=7637161898514, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在, objectType=article, longId=163131, objectId=90c11631319d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90c11631319d, replyNumber=0, likeNumber=0, createdTime=2019-03-29, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90c11631319d, moduleTitle=Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90c11631319d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618984, encodeId=80ad161898459, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=Hepatology：与单纯HCV感染者相比，HIV/HCV感染的肝硬化患者不再具有更高的肝癌或晚期肝病风险, objectType=article, longId=159339, objectId=4c75159339c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c75159339c3, replyNumber=0, likeNumber=35, createdTime=2019-02-02, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c75159339c3, moduleTitle=Hepatology：与单纯HCV感染者相比，HIV/HCV感染的肝硬化患者不再具有更高的肝癌或晚期肝病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c75159339c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618983, encodeId=0c46161898313, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, objectType=article, longId=157446, objectId=175b15e44699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175b15e44699, replyNumber=0, likeNumber=30, createdTime=2019-01-08, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175b15e44699, moduleTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175b15e44699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618982, encodeId=3a6f16189821b, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译, objectType=article, longId=151373, objectId=d2bb1513e302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2bb1513e302, replyNumber=0, likeNumber=21, createdTime=2018-10-20, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2bb1513e302, moduleTitle=《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2bb1513e302)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618981, encodeId=3bc7161898192, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=J Diabetes：复旦大学附属中山医院于明香教授团队研究：HCV感染使肾移植患者糖尿病风险增加3倍, objectType=article, longId=150299, objectId=616d150299d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616d150299d0, replyNumber=0, likeNumber=38, createdTime=2018-10-04, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616d150299d0, moduleTitle=J Diabetes：复旦大学附属中山医院于明香教授团队研究：HCV感染使肾移植患者糖尿病风险增加3倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616d150299d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618980, encodeId=570816189809d, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=Lancet Gastroen Hepatol：索非布韦联合维帕他韦对吸毒患者的HCV感染有效, objectType=article, longId=125922, objectId=d0621259220a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0621259220a, replyNumber=0, likeNumber=22, createdTime=2018-01-10, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0621259220a, moduleTitle=Lancet Gastroen Hepatol：索非布韦联合维帕他韦对吸毒患者的HCV感染有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0621259220a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618979, encodeId=d7a916189e9d2, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=J Gastroen Hepatol：糖尿病加速HCV感染者的癌变进程, objectType=article, longId=104993, objectId=825e104993ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=825e104993ad, replyNumber=0, likeNumber=37, createdTime=2017-07-10, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=825e104993ad, moduleTitle=J Gastroen Hepatol：糖尿病加速HCV感染者的癌变进程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=825e104993ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618978, encodeId=d3b316189e88f, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=Gut：持续病毒应答对HCV感染肝外表现的风险影响, objectType=article, longId=102795, objectId=4984102e956f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4984102e956f, replyNumber=0, likeNumber=33, createdTime=2017-06-23, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4984102e956f, moduleTitle=Gut：持续病毒应答对HCV感染肝外表现的风险影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4984102e956f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618977, encodeId=41e716189e768, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=GUT：抗病毒药物治疗慢性HCV感染对脂质的影响, objectType=article, longId=102292, objectId=78a6102292a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a6102292a3, replyNumber=0, likeNumber=40, createdTime=2017-06-19, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a6102292a3, moduleTitle=GUT：抗病毒药物治疗慢性HCV感染对脂质的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78a6102292a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618976, encodeId=dc8516189e67f, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=NEJM：3D疗法用于各型先前治疗失败的HCV感染者, objectType=article, longId=100377, objectId=cdf71003e703, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdf71003e703, replyNumber=0, likeNumber=24, createdTime=2017-06-03, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdf71003e703, moduleTitle=NEJM：3D疗法用于各型先前治疗失败的HCV感染者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdf71003e703)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618975, encodeId=436016189e579, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=AIM：Harvoni治疗HCV感染的肾移植受者的疗效研究, objectType=article, longId=82664, objectId=cb7b82664df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7b82664df, replyNumber=0, likeNumber=47, createdTime=2016-11-20, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7b82664df, moduleTitle=AIM：Harvoni治疗HCV感染的肾移植受者的疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb7b82664df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618974, encodeId=7b5a16189e4ce, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=Nat Cell Biol：挑战常规！发现人肝细胞抵抗HCV感染的代谢过程, objectType=article, longId=80160, objectId=5dec801601d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dec801601d, replyNumber=0, likeNumber=33, createdTime=2016-10-17, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dec801601d, moduleTitle=Nat Cell Biol：挑战常规！发现人肝细胞抵抗HCV感染的代谢过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dec801601d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618973, encodeId=684516189e36f, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=Aliment Pharmacol Ther：直接抗病毒治疗老年HCV感染患者, objectType=article, longId=77223, objectId=1ad0e722374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ad0e722374, replyNumber=0, likeNumber=25, createdTime=2016-09-13, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ad0e722374, moduleTitle=Aliment Pharmacol Ther：直接抗病毒治疗老年HCV感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ad0e722374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618972, encodeId=18a916189e2f9, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=J Hepatol：索非布韦+达卡他韦治疗基因1型HCV感染, objectType=article, longId=77206, objectId=99bee720672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99bee720672, replyNumber=0, likeNumber=33, createdTime=2016-09-13, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99bee720672, moduleTitle=J Hepatol：索非布韦+达卡他韦治疗基因1型HCV感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99bee720672)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618971, encodeId=cb1816189e181, content=<a href='/topic/show?id=5f1785e9d5' target=_blank style='color:#2F92EE;'>#HCV感染#</a>, objectTitle=治愈HCV感染，我们需要付出多大代价？, objectType=article, longId=76084, objectId=db5be608458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db5be608458, replyNumber=0, likeNumber=43, createdTime=2016-08-30, rootId=0, userName=12498e5fm18(暂无昵称), userId=9cb419968800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db5be608458, moduleTitle=治愈HCV感染，我们需要付出多大代价？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db5be608458)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

CGH：37项临床试验的数据分析表明，使用DAA治疗HCV感染与VZV再激活风险增加之间无关联

2021-09-16

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

NEJM：预防慢性HCV感染的疫苗是否有效？

2021-02-13

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Lancet Gastroen Hepatol：索非布韦联合雷迪帕韦治疗患有慢性肾病的HCV感染患者

2020-06-12

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

《2018年意大利肝病学会专家共识：免疫功能低下患者HCV感染》摘译

2019-04-30

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

NEJM：HCV感染供体的心肺移植

2019-04-27

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Gastroenterology：HCV感染引起的与肝癌风险相关的表观遗传改变在持续的病毒学应答后持续存在

2019-03-29

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Hepatology：与单纯HCV感染者相比，HIV/HCV感染的肝硬化患者不再具有更高的肝癌或晚期肝病风险

2019-02-02

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析

2019-01-08

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译

2018-10-20

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

J Diabetes：复旦大学附属中山医院于明香教授团队研究：HCV感染使肾移植患者糖尿病风险增加3倍

2018-10-04

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Lancet Gastroen Hepatol：索非布韦联合维帕他韦对吸毒患者的HCV感染有效

2018-01-10

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

J Gastroen Hepatol：糖尿病加速HCV感染者的癌变进程

2017-07-10

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Gut：持续病毒应答对HCV感染肝外表现的风险影响

2017-06-23

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

GUT：抗病毒药物治疗慢性HCV感染对脂质的影响

2017-06-19

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

NEJM：3D疗法用于各型先前治疗失败的HCV感染者

2017-06-03

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

AIM：Harvoni治疗HCV感染的肾移植受者的疗效研究

2016-11-20

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Nat Cell Biol：挑战常规！发现人肝细胞抵抗HCV感染的代谢过程

2016-10-17

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

Aliment Pharmacol Ther：直接抗病毒治疗老年HCV感染患者

2016-09-13

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

J Hepatol：索非布韦+达卡他韦治疗基因1型HCV感染

2016-09-13

12498e5fm18(暂无昵称) (审核中...)

前往app查看评论内容

#HCV感染#

治愈HCV感染，我们需要付出多大代价？

2016-08-30

科室
- - 订阅+
  - 更多科室
工具
服务